MedPath

PDP-DESONIDE

PDP-DESONIDE

Approved
DIN Number

02229315

Drug Class

Human

Market Date

Jan 14, 1997

Company
HC

pendopharm division of pharmascience inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02229315
AIG Number0106367001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D07AB08 DESONIDE
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification84:06.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DESONIDEActive
Strength: 0.05 % / W/W
Monograph: DESONIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.